New Delhi: People who are infected should also take a vaccine, and India is well prepared regarding the logistics for the vaccine distribution, Bharat Biotech Chairman & MD Krishna Ella said on Wednesday.
He was speaking in a virtual session on 'Sero surveillance significance in immunogenicity and safety in pre and post vaccination era' organised by industry body CII.
For the people who are infected, should they take a vaccine, "the answer is yes", because they may not have a good T cells response..., Ella said.
Talking about the company's efficacy trials of its COVID-19 vaccine, he said that for the efficacy trials the company has taken 24 centres all over the country so that it has tier I ,tier II and tier III cities to capture the efficacy in a better way.
On the distribution of vaccines in India, he said India is well prepared for that and Indian immunisation system is very robust, Ella said.